Stand-Up MRI sales helps Fonar keep revenues steady

Sales of its upright Stand-Up MRI system helped Fonar Corp. offset lower revenues in other business segments in the company first fiscal quarter of FY04, ending Sept. 30.

 Revenues held steady at $13.3 million, the same total as the first quarter of FY03. Revenues from the MRI equipment sales rose to $7.3 million, up 3 percent from $7.1 million in the same quarter of FY03. The company also posted a net loss of $3.8 million, compared with a net loss of $2.7 million in the year-ago quarter.

 Fonar blamed increased expenses from efforts to improve equipment sales volume, coupled with decreased revenues from product sales to related parties as the primary reasons for its first-quarter net loss.

Around the web

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.

The newly cleared offering, AutoChamber, was designed with opportunistic screening in mind. It can evaluate many different kinds of CT images, including those originally gathered to screen patients for lung cancer. 

Trimed Popup
Trimed Popup